HCV knowledge among a sample of HCV positive Aboriginal Australians residing in New South Wales

References

• Alavi, M., Grebely, J., Micallef, M., Dunlop, A. J., Balcomb, A. C., Day, C. A., … on behalf of the Enhancing Treatment for Hepatitis C in Opioid Substitution Settings Study Group. (2013). Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study. Clinical Infectious Diseases, 57, S62–S69. doi:10.1093/cid/cit305
   PubMed Web of Science ®Google Scholar
• Australian Government Department of Health and Ageing. (2010). Third national hepatitis C strategy 2010–2013. Canberra (AUST): Commonwealth of Australia.
   Google Scholar
• Australian Insitute of Health and Welfare. (2004). Rural, regional and remote health: A guide to remoteness classification (Rural Health Series No. 4). Canberra (AUST): Australian Institute of Health and Welfare.
   Google Scholar
• Balfour, L., Kowal, J., Corace, K. M., Tasca, G. A., Krysanski, V., Cooper, C. L., & Garber, G. (2009). Increasing public awareness about hepatitis C: Development and validation of the brief hepatitis C knowledge scale. Scandinavian Journal of Caring Sciences, 23, 801–808. doi:10.1111/j.1471-6712.2008.00668.x
   PubMed Web of Science ®Google Scholar
• Boonwaat, L., Haber, P., Levy, M., & Lloyd, A. (2010). Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C. Medical Journal of Australia, 192, 496–500.
   PubMed Web of Science ®Google Scholar
• Bryant, J. (2014). A study of young people who inject drugs: An opportunity to decrease high risk injecting by improving knowledge about hepatitis C prevention. Vulnerable Children and Youth Studies, 9, 104–113. doi:10.1080/17450128.2013.855348
   Google Scholar
• Doab, A., Treloar, C., & Dore, G. J. (2005). Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clinical Infectious Diseases, 40, S313–S320. doi:10.1086/427446
   PubMed Web of Science ®Google Scholar
• Grebely, J., Bryant, J., Hull, P., Hopwood, M., Lavis, Y., Dore, G. J., & Treloar, C. (2011). Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia. Journal of Viral Hepatitis, 18, e104–e116. doi:10.1111/j.1365-2893.2010.01370.x
   PubMed Web of Science ®Google Scholar
• Hopwood, M., Brener, L., & Wilson, H. (2012). Vaccine, transmission and treatment: An exploratory study of viral hepatitis knowledge among attendees of a metropolitan Australian university. Drugs: Education, Prevention, and Policy, 19, 346–350. doi:10.3109/09687637.2012.675530
   Web of Science ®Google Scholar
• Jost, J. J., Goldsamt, L. A., Harocopos, A., Kobrak, P., & Clatts, M. C. (2010). Hepatitis C knowledge among new injection drug users. Drugs: Education, Prevention and Policy, 17, 821–834.
   Web of Science ®Google Scholar
• Kirby Institute. (2012). Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: Surveillance and evaluation report, 2012. Sydney (AUST): Kirby Institute, UNSW.
   Google Scholar
• Maher, L., Li, J., Jalaludin, B., Chant, K. G., & Kaldor, J. M. (2007). High hepatitis C incidence in new injecting drug users: a policy failure? Australian and New Zealand Journal of Public Health, 31, 30–35. doi:10.1111/j.1753-6405.2007.00007.x
   PubMed Web of Science ®Google Scholar
• Munoz-Plaza, C. E., Strauss, S., Astone-Twerell, J., Jarlais, D. D., Gwadz, M., Hagan, H., … Rosenblum, A. (2008). Exploring drug users’ attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S. International Journal of Drug Policy, 19, 71–78. doi:10.1016/j.drugpo.2007.02.003
   PubMed Web of Science ®Google Scholar
• National Indigenous Drug and Alcohol Committee. (2012). An economic analysis for Aboriginal and Torres Strait Islander offenders – prison vs. residential treatment (ANCD research paper 24). Canberra (AUST): Australian National Council on Drugs.
   Google Scholar
• O’Brien, S., Day, C., Black, E., & Dolan, K. (2008). Injecting drug users’ understanding of hepatitis C. Addictive Behaviors, 33, 1602–1605. doi:10.1016/j.addbeh.2008.07.005
   PubMed Web of Science ®Google Scholar
• Paquette, D., McEwan, M., & Bryant, J. (2013). Risk practices among aboriginal people who inject drugs in New South Wales. Australia. AIDS and Behavior, 17, 2467–2473.
   PubMed Web of Science ®Google Scholar
• Perz, J. F., Farrington, L. A., Pecoraro, C., Hutin, Y. J. F., & Armstrong, G. L. (2004). Estimated global prevalence of hepatitis C virus infection. 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, MA.
   Google Scholar
• van der Poorten, D., Kenny, D. T., & George, J. (2008). Prevalence of and risk factors for hepatitis C in Aboriginal and non-Aboriginal adolescent offenders. Medical Journal of Australia, 188, 610–614.
   PubMed Web of Science ®Google Scholar
• Smyth, B. P., McMahon, J., O’Connor, J. J., & Ryan, J. (1999). Knowledge regarding hepatitis C among injecting drug users. Drugs: Education, Prevention, and Policy, 6, 257–264. doi:10.1080/09687639997214
   Web of Science ®Google Scholar
• Strathdee, S. A., Latka, M., Campbell, J., Campbell, J., O’Driscoll, P. T., Golub, E. T., Kapadia, F., … Project, S. t. R. I. E. (2005). Factors associated with interest in initiating treatment for hepatitis C virus (HCV) infection among young HCV-infected injection drug users. Clinical Infectious Diseases, 40, S304–S312. doi:10.1086/427445
   PubMed Web of Science ®Google Scholar
• Strauss, S., Astone-Twerell, J., Munoz-Plaza, C., Des Jarlais, D., Gwadz, M., Hagan, H., … Rosenblum, A. (2007). Drug treatment program patients’ hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Services Research, 7, 39.10.1186/1472-6963-7-39
   PubMed Web of Science ®Google Scholar
• The Global Burden of Disease Working Group. (2004). Global burden of disease (GBD) for hepatitis C. Journal of Clinical Pharmacology, 44, 20–29. doi:10.1177/0091270003258669
   PubMed Web of Science ®Google Scholar
• Treloar, C., Hull, P., Bryant, J., Hopwood, M., Grebely, J., & Lavis, Y. (2011). Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs. Drug and Alcohol Dependence, 116, 52–56. doi:10.1016/j.drugalcdep.2010.11.018
   PubMed Web of Science ®Google Scholar
• Treloar, C., Hull, P., Dore, G. J., & Grebely, J. (2012). Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs. Drug and Alcohol Review, 31, 918–924. doi:10.1111/j.1465-3362.2012.00468.x
   PubMed Web of Science ®Google Scholar
• Treloar, C., Jackson, C., Gray, R., Newland, J., Wilson, H., Saunders, V., … Brener, L. (2015). Care and treatment of hepatitis C among Aboriginal people in New South Wales, Australia: Implications for the implementation of new treatments. Ethnicity & Health, 21, 39–57. doi:10.1080/13557858.2015.1004870
   PubMed Web of Science ®Google Scholar
• Treloar, C., Jackson, L. C., Wilson, H. E., Saunders, V., Brener, L., Johnson, P., … Gray, R. (2014). A Study of Aboriginal people in NSW living with hepatitis C: A report to community (Monograph 4e/2014). Sydney (AUST): Centre for Social Research in Health, UNSW.
   Google Scholar